Treatment guided by cerebral oximetry monitoring for the first 72 hours after birth failed to improve survival for extremely preterm infants, the SafeBoosC-III trial found. At 36 weeks postmenstrual ...
The use of cerebral oximetry monitoring in the care of extremely preterm infants is increasing. However, evidence that its use improves clinical outcomes is lacking. In this randomized, phase 3 trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results